论文信息 - Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. - 字舞流文

Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.

E. Shpall | R. Chemaly | E. Ariza-Heredia | D. Shah | V. Mulanovich | Firas El Chaer | Danielle El-Haddad | J. Vanichanan | A. Gulbis | F. El Chaer